Correlation between oculometric measures and clinical assessment in ALS patients participating in a phase IIb clinical drug trial

Overview of attention for article published in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, April 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news: 2 news outlets

twitter: 3 X users

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 2 news stories from 2 outlets.

New assessment tool for ALS based on abnormal eye movements

Verdict Medical Devices, 26 Apr 2023

A software platform developed by NeuraLight to evaluate eye movement abnormalities could soon be used to help assess…

Correlation between oculometric measures and clinical assessment in ALS patients participating in a phase IIb clinical drug trial.

Alzforum, 14 Apr 2023

Raveh E, Ben-Shimon A, Anisimov V, Kreitman R, Ben-Ami E, Nechushtan E, Birman N, Drory VE.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.